|
RNA aptamers against PSMA
|
1) siRNA (non-covalently conjugate siRNA with aptamer via a streptavidin connector [49]; aptamer-siRNA chimeras [17, 18] and bivalent aptamer-siRNA conjugates [77]).
|
| |
2) Toxin [73] (chemically covalently conjugate toxin with aptamer via SPDP reagent)
|
| |
3) Nanoparticles and chemotherapeutic agents [62–70] (cargoes such as dextran, docetaxel, Pt(IV) and doxorubicin were encapsulated into aptamer-coated nanoparticles; aptamer-Dox physical conjugates via intercalation interaction)
|
|
RNA aptamers against CD4
|
siRNA [25] (non-covalently assemble pRNA-siRNA chimera with pRNA-aptamer chimera into dimer or trimer)
|
|
RNA aptamers against HIV gp120
|
siRNA [19, 20] (aptamer-siRNA chimeras; non-covalently conjugate siRNA with aptamer via a 'sticky bridge')
|
|
RNA aptamers against TN-C
|
Radionuclide and fluorescent agents (chemically covalently conjugate 99mTc or fluorescent agents with aptamers)
|
|
DNA aptamers against PTK7
|
1) Doxorubicin [93] (chemically covalently conjugate Dox with aptamer via an acid-labile linkage)
|
| |
2) Viral capsid [94] (chemically covalently conjugate MS2 viral capsid with aptamer via an oxidative coupling reaction)
|
|
DNA aptamers against TfR
|
Enzyme [74] (chemically covalently conjugate a-L-iduronidase with aptamer via an oxidative coupling reaction)
|
|
DNA aptamers against NCL
|
Liposomes and chemotherapeutic agents [71] (cisplatin was encapsulated into liposomes that was non-covalently coated with aptamers)
|
|
DNA aptamers against MUC1
|
Photodynamic therapy agents [72] (chemically covalently conjugate chlorine e6 with aptamer via EDC chemistry)
|